NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Tellus BioVentures

Tellus BioVentures

Overview

Tellus BioVentures is a biotechnology investment fund focused on early-stage innovation and company formation. The fund uncovers and accelerates promising life science innovations and enables talented entrepreneurs and innovators to bring their ideas to fruition. They make select investments at the Seed stage and participate in Series-A investments, often as lead or sole investors. Their mission is to serve patients with unmet needs by launching and funding new biotech ventures.

Year Founded

2019

Portfolio Companies

7

Investments

Tellus BioVentures investments
CompanyDateStageLead
Vittoria BiotherapeuticsNov 2024Private Financing ExtensionCo-investor
Cantai TherapeuticsNov 2023SeedCo-investor
Vittoria BiotherapeuticsNov 2023Series ACo-investor
PraeventixNov 2022SeedCo-investor
Vittoria BiotherapeuticsJun 2022SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersFlorida
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.